Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 234Carcinoma, Non-Small-Cell Lung 132Breast Neoplasms 121Glioblastoma 88Ovarian Neoplasms 86Carcinoma, Hepatocellular 69Rectal Neoplasms 64Brain Neoplasms 58Lung Neoplasms 55Neoplasm Metastasis 54Neoplasms 52Colonic Neoplasms 50Fallopian Tube Neoplasms 43Glioma 40Carcinoma, Renal Cell 35Gliosarcoma 34Melanoma 26Adenocarcinoma of Lung 26Pancreatic Neoplasms 23Liver Neoplasms 23Uterine Cervical Neoplasms 21Stomach Neoplasms 21Recurrence 21Triple Negative Breast Neoplasms 18Kidney Neoplasms 16Endometrial Neoplasms 16Esophageal Neoplasms 15Astrocytoma 14Carcinoma, Ovarian Epithelial 13Adenocarcinoma, Bronchiolo-Alveolar 13

Interventions

cabazitaxel 3Trastuzumab 3Cyclophosphamide 2Cetuximab 2Carboplatin 2Aspirin 2ribociclib 1pertuzumab 1eribulin 1Thiotepa 1Taxes 1Stem Cell Transplantation 1Propofol 1Positron Emission Tomography Computed Tomography 1Paclitaxel 1Neoadjuvant Therapy 1Liquid Biopsy 1Letrozole 1Ipilimumab 1Histamine H2 Antagonists 1Histamine Antagonists 1Gemcitabine 1Fulvestrant 1Epirubicin 1Docetaxel 1Denosumab 1Circulating Tumor DNA 1Cell-Free Nucleic Acids 1CA-72-4 antigen 1CA-19-9 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Neoplastic Cells, Circulating × Bevacizumab × Clear all
NCT01640444 2019-04-11

VISNU-2

Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

Phase 2 Completed
240 enrolled
Gastrointestinal

Neoplastic Cells, Circulating, Hereditary Sensory and Autonomic Neuropathies, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡